| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.14 | 0.3 |